Cathy McCarty is a partner in Goodwin’s Technology and Life Sciences groups, and a co-chair of Goodwin’s Intellectual Property practice group. Ms. McCarty works with clients to protect their innovations and procure intellectual property through intellectual property strategies that are integrated with each client’s business goals. She works with public and private companies of all sizes and stages of development, including venture funded start-ups, venture capital partnerships and entities that invest in, or evaluate, pharmaceutical and life science companies and technologies.

Ms. McCarty specializes in intellectual property relating to pharmaceuticals and general chemistry matters, including small molecule drugs, salt forms, solid forms and chemical processes. She also has worked on various litigation matters involving pharmaceutical and chemical products.

Ms. McCarty approaches each client and each matter with the drive and focus required to master the project at hand. She works to integrate the intellectual property with the practical business issues faced by the client, including scientific, financial, regulatory and competitive issues. Her client projects are varied and include designing and managing worldwide patent estates on drug candidates, evaluating competitive landscapes to determine patentability and freedom to operate, procuring IP strategy for early stage start-up companies, performing IP due diligence for investors, and advising on license agreements, collaborations and regulatory issues.

Prior to joining Goodwin in 2017, Ms. McCarty was a partner at Lando & Anastasi LLP.





Professional Experience

Ms. McCarty previously served as a medicinal chemist in drug discovery at Vertex Pharmaceuticals, Abbott Laboratories, and Parke-Davis (now Pfizer); she is an inventor on five issued U.S. Patents.


Ms. McCarty has been recognized by The Best Lawyers in America Best Lawyers for her work in Biotechnology and Life Sciences Practice, and Patent Law 2022-2023.

Ms. McCarty was a recommended lawyer for Patents: Licensing by The Legal 500 in 2021 and 2022.

In The News









J.D., 2002
Harvard Law School
M.S., Chemistry
Yale University
B.S., Chemistry
Indiana University



U.S. Patent and Trademark Office (USPTO)
Profile Image
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.


Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Search Other Lawyers
Recherche par Pratique